730 related articles for article (PubMed ID: 11899146)
21. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of ultraviolet A1 phototherapy on the expression of bcl-2 in atopic dermatitis and cutaneous T-cell lymphoma in vivo: a comparison study.
Breuckmann F; von Kobyletzki G; Avermaete A; Kreuter A; Altmeyer P
Photodermatol Photoimmunol Photomed; 2002 Oct; 18(5):217-22. PubMed ID: 12390661
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the Effect of Gentian Violet on Apoptosis and Proliferation in Cutaneous T-Cell Lymphoma in an In Vitro Study.
Wu J; Wood GS
JAMA Dermatol; 2018 Oct; 154(10):1191-1198. PubMed ID: 30167641
[TBL] [Abstract][Full Text] [Related]
24. T-cell-rich large-B-cell lymphomas contain non-activated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower Bcl-2 expression than diffuse large-B-cell lymphomas.
Felgar RE; Steward KR; Cousar JB; Macon WR
Am J Pathol; 1998 Dec; 153(6):1707-15. PubMed ID: 9846961
[TBL] [Abstract][Full Text] [Related]
25. Lymphomatoid Papulosis (LyP) Associated with Diffuse Large B-cell Lymphoma and Cutaneous Anaplastic Large Cell Lymphoma: LyP as a Haematological Malignancy-related Dermadrome.
Miyagawa F; Iioka H; Asada H
Acta Derm Venereol; 2018 Aug; 98(8):799-800. PubMed ID: 29796688
[No Abstract] [Full Text] [Related]
26. Lymphomatoid papulosis.
Sica A; Vitiello P; Sorriento A; Ronchi A; Calogero A; Sagnelli C; Troiani T; Fasano M; Dodaro CA; Franco R; Casale B; Santangelo M; Ciccozzi M; Ciardiello F; Argenziano G; Moscarella E
Minerva Med; 2020 Apr; 111(2):166-172. PubMed ID: 31958921
[TBL] [Abstract][Full Text] [Related]
27. Expression of Fas and Fas ligand in cutaneous B-cell lymphomas.
Zoi-Toli O; Meijer CJ; Oudejans JJ; de Vries E; van Beek P; Willemze R
J Pathol; 1999 Dec; 189(4):533-8. PubMed ID: 10629554
[TBL] [Abstract][Full Text] [Related]
28. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
An S; Yap D; Knox KA
Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
[TBL] [Abstract][Full Text] [Related]
29. Decreased expression of Fas (APO-1/CD95) on peripheral blood CD4+ T lymphocytes in cutaneous T-cell lymphomas.
Dereure O; Portales P; Clot J; Guilhou JJ
Br J Dermatol; 2000 Dec; 143(6):1205-10. PubMed ID: 11122022
[TBL] [Abstract][Full Text] [Related]
30. Testosterone promotes apoptotic damage in human renal tubular cells.
Verzola D; Gandolfo MT; Salvatore F; Villaggio B; Gianiorio F; Traverso P; Deferrari G; Garibotto G
Kidney Int; 2004 Apr; 65(4):1252-61. PubMed ID: 15086464
[TBL] [Abstract][Full Text] [Related]
31. Expression of apoptosis proteins in chronic myelogenous leukemia: associations and significance.
Ravandi F; Kantarjian HM; Talpaz M; O'Brien S; Faderl S; Giles FJ; Thomas D; Cortes J; Andreeff M; Estrov Z; Rios MB; Albitar M
Cancer; 2001 Jun; 91(11):1964-72. PubMed ID: 11391574
[TBL] [Abstract][Full Text] [Related]
32. Expression of apoptosis markers on peripheral blood lymphocytes from patients with cutaneous T-cell lymphoma during extracorporeal photochemotherapy.
Osella-Abate S; Zaccagna A; Savoia P; Quaglino P; Salomone B; Bernengo MG
J Am Acad Dermatol; 2001 Jan; 44(1):40-7. PubMed ID: 11148475
[TBL] [Abstract][Full Text] [Related]
33. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
[TBL] [Abstract][Full Text] [Related]
34. The utility of the in situ detection of T-cell receptor Beta rearrangements in cutaneous T-cell-dominant infiltrates.
Magro CM; Nuovo GJ; Crowson AN
Diagn Mol Pathol; 2003 Sep; 12(3):133-41. PubMed ID: 12960695
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
Paulli M; Berti E
Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
[TBL] [Abstract][Full Text] [Related]
36. Long-term Follow-up of a Case of Lymphomatoid Papulosis with a Benign Course.
Balić A; Bartolić L; Ilić I; Radoš J
Acta Dermatovenerol Croat; 2018 Oct; 26(3):264-266. PubMed ID: 30390731
[TBL] [Abstract][Full Text] [Related]
37. [Lymphomatoid papulosis type C or transition to CD30+-T-cell lymphoma? A difficult differential diagnosis].
Plettenberg H; Neumann NJ; Ruzicka T; Megahed M
Hautarzt; 2003 Apr; 54(4):366-8. PubMed ID: 12669213
[TBL] [Abstract][Full Text] [Related]
38. Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption.
Choi HJ; Ku JK; Kim MY; Kang H; Cho SH; Kim HO; Park YM
Br J Dermatol; 2006 Mar; 154(3):419-25. PubMed ID: 16445769
[TBL] [Abstract][Full Text] [Related]
39. Progression of lymphomatoid papulosis to systemic lymphoma is associated with escape from growth inhibition by transforming growth factor-beta and CD30 ligand.
Kadin ME; Levi E; Kempf W
Ann N Y Acad Sci; 2001 Sep; 941():59-68. PubMed ID: 11594583
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
